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PRETREATMENT of human neutrophils with recombinant
tumour necrosis factor-alpha (rTNF-) and/or interleu-
kin-8 (rIL-8), but not with either transforming growth
factor-beta, interleukin-6 or interferon-gamma, rendered
these cells less responsive to FMLP, in microchemotaxis
assays. This inhibitory effect was dose dependent and
more powerful when neutrophils were pretreated with a
mixture of both cytokines. Intravenous injection ofhuman
rIL-8 (hrlL-8) and/or murine rTNF- (mrTNF-) also
significantly reduced in vivo neutrophil migration into
peritoneal cavities of rats stimulated with carrageenan.
These data suggest that the defect in neutrophil migration
during septicaemia or endotoxaemia may be the result of
the continuous release of IL-8 and TNF- into the circula-
tion. Thus, either the selective control or blockade of
releasing of these cytokines as well as of its effects on
neutrophils may be clinically useful in reestablishing the
cell defence mechanisms.
Key words: Human neutrophils, Interleukin-8, Tumour necro-
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Introduction
Several studies have established the fact that
Gram-negative bacteraemia or circulating en-
dotoxin decreases the ability of neutrophils (PMN)
to migrate to inflammation sites.
1-3 This effect may
play an important role in the evolution of
septicaemia. 1’4 Neutrophil inhibitory factors have
been found in many other illnesses, such as AIDS,
Hodgkin’s disease,
6 diabetes mellitus and leproma-
tous leprosy. The source of these factors has not
yet been satisfactorily demonstrated. It has been
shown that macrophages incubated with Staphylo-
coccus aureus release a factor(s) which inhibits
neutrophil migration in vitro.9J Recently it has been
shown that the supernatant of rat macrophages
pretreated with lipopolysaccharide (LPS) admin-
istered intravenously (i.v.) suppresses the recruit-
ment of neutrophils to the peritoneal exudate
induced by various inflammatory stimuli, thus
mimicking the effects of LPS. The factor(s)
present in this supernatant was named NRIF
(neutrophil recruitment inhibitory factor).
1
Tumour necrosis factor-alpha (TNF-o0 and
interleukin 8 (IL-8) exert a wide spectrum of
activities in inflammatory reaction. They are potent
stimulators of several neutrophil functions, includ-
ing chemotaxis, respiratory burst, degranulation
and aggregation.
2-9 Besides these pro-inflamma-
tory effects, it was recently demonstrated that both
cytokines have anti-inflammatory properties. 13’2-24
TNF-o blocks in vitro chemotaxis of human and
rabbit neutrophils induced by several stimuli, such
(C) 1992 Rapid Communications of Oxford Ltd
as f-methionyl, 1-1eucyl phenylalanine (FMLP) Cha
and LTB420-22’24 and IL-8 inhibits neutrophil
adhesion to cytokine activated endothelial mono-
layers resulting in the protection of these cells from
neutrophil mediated damage in vitro.
2 It was also
shown that the intravenous injection of TNF
inhibited Cha induced neutrophil emigration into
skin of mice,
24 and that systemic administration of
IL-8 caused a similar effect in the skin of rabbits
challenged with FMLP, IL-1, C5a or LTB4 .2s
In the present investigation the effect of TNF-
and IL-8, alone or in combination, on neutrophil
migration has been investigated in vitro. The effect
of transforming growth factor-fl, interleukin-lfl,
interleukin-6 and interferon-gamma were also
tested. Since TNF-0 and IL-8 inhibited neutrophil
chemotaxis induced by FMLP, the effect of
intravenous administration of these cytokines on
carrageenan induced neutrophil recruitment in
peritoneal cavities of rats was also tested.
Materials and Methods
Animals: Adult male Sprague-Dawley rats weighing
150-180g were obtained from Charles River
Breeding Laboratories (Wilmington, MA).
Reagents: The following human recombinant cyto-
kines were used: tumour necrosis factor-alpha
(hrTNF<z) and interleukin-8 (hrIL-8) from Genen-
tech Inc. Transforming growth factor-beta
(hrTOF-fl), interleukin-lbeta (hrIL-lfl), interferon-
gamma (hrlFN-,) and interleukin-6 (hrIL-6) from
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Genzyme Corp. (Boston, MA). Murine re-
combinant tumour necrosis factor-alpha (mrTNF-
z) from Genentech Inc. was used in some
experiments.
In vitro neutrophil migration: Preparation of human
neutrophils: Viable human neutrophils were
obtained from heparinized venous blood of healthy
subjects by monopolyresolving medium (Flow
Laboratories) fractionation. The isolated neu-
trophils were washed three times in RPMI 1640
medium and then suspended in the same medium
containing 0.1% bovine seru.m albumin (BSA;
Sigma, St Louis).
Pretreatment of neutrophils: Neutrophil suspen-
sions (106 cells/ml) were incubated for 30 min, at
37C in a humidified incubator with 5% CO2, either
in the absence or in the presence of various
concentrations of human recombinant cytokines
(10-v-10-11M) (hrWNF-, hrIL-8, hrhWOF-fl,
hrIL-lfl, hrlFN-2 and hrlL-6), prior to testing for
chemotactic response to f-methionyl,l-leucyl phe-
nylalanine (FMLP) (Sigma, St Louis) in micro-
chemotaxis assays. The cytokines were present
throughout the assay. In some experiments,
neutrophils were exposed to 10-7M of mrTNF-
and/or hrlL-8 for 30 min and subsequently washed
with RPMI medium, prior to testing for responsive-
ness to FMLP.
Chemotaxis assay: Chemotaxis was assessed in a
48-well microchemotaxis chambers (Neuro Probe,
Cabin John, MD) separated by 5/.tm pore
size polyvinylpyrrolidone-free polycarbonate
membranes. Twenty-five ftl of FMLP (10
-8 M)
diluted in RPMI containing 0.1% BSA were placed
in the bottom chamber and 50#1 of PMN
suspensions (106 cells/ml) were added to the top
chamber. The chambers were incubated for 1 h at
37C in a humidified incubator with 5% of CO2.
Subsequently, the filters were removed, fixed, and
stained with Diff-Quick Stain Kit (American
Scientific Products, McGraw Park, IL). Neutro-
phils, which migrated to the lower side of the
filter were counted by using a 100 x objective in
five random fields. Experiments were performed in
triplicate for each variable and the mean de-
termined. The results were expressed as number of
neutrophils/field. In each experiment untreated
neutrophils migrating toward FMLP were used as
a positive reference.
In vivo neutrophil migration:
Effect of cytokines on in vivo neutrophil
migration" Murine recombinant TNF- and/or
human recombinant IL-8 (2/tg/0.5 ml/animal) were
injected i.v. into a tail vein of male rats. Thirty
minutes later, the animals received an intraperi-
toneal (i.p.) injection of carrageenan (1 mg/3 ml of
PBS; Sigma). The number of peritoneal neutrophils
was evaluated 4 h after the i.p. injection. Rats were
sacrificed with CO2, their peritoneal cavities were
washed with 10 ml of PBS containing 5 IU/ml of
heparin and the total and differential cell counts
were determined. The results were reported as the
average number of neutrophils per cavity.
Statistics: The results are reported as the mean 4- the
standard error of the mean (S.E.M.) Values of p
were determined using Student’s t-test.
Results
Human recombinant TNF- (10-7M) sup-
pressed profoundly human neutrophil chemotaxis
to FMLP. Interleukin-8, at the same concentration,
was less effective at inhibiting neutrophil chemo-
taxis. In contrast, hrTGF-/, hrIL-1/, hrIFN-2 and
hrlL-6 were ineffective (Fig. 1). The inhibitory
effects of hrIL-8 and hrTNF- on neutrophil
chemotaxis were dose dependent. While hrIL-8 had
significant inhibitory effect on chemotaxis only at
the doses of 10
-7 and 10
-8 M, hrTNF-z exhibited
a significant inhibitory effect upon neutrophil
migration at a concentration as low as 10-10 M. The
combination of hrTNF-z plus hrlL-8 had a strong
inhibitory effect on neutrophil chemotaxis at all
concentrations tested (10-
7 to 10-11 M) (Fig. 2).
Exposure of neutrophils to 10-7M hrIL-8 and
mrTNF- either alone or in combination, followed
by cell washing, also resulted in inhibition
of neutrophil chemotaxis (Fig. 3).
Intravenous administration of mrTNF-0, hrlL-8
or a mixture of both reduced neutrophil migration
induced by an i.p. injection of carrageenin.
Similar to the in vitro results, mrTNF- was more
potent than hrlL-8 in relation to the inhibition of
neutrophil migration into the peritoneal cavities
of rats (Fig. 4).
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FIG. 1. Effects of cytokines on neutrophil chemotaxis induced by FMLP.
The concentration of the cytokines was 10-7 M. Results are reported as
means +_ S.E.M. of the number of neutrophils per field. Average number
of fields was 15 for each variable. (*p < 0.01, Student’s t-test.)
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FIG. 2. Dose response effect of hrTNF- and hrlL-8, individually or combined, on neutrophil chemotaxis induced by FMLP. Subtitles indicate
molar concentration of each cytokine used either alone or in combination. Results are reported as means _+ S.E.M. of the number of neutrophils per
field, which were 15 on average. (*p < 0.01, Student’s t-test.)
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FIG. 3. Effect of pretreatment of neutrophils with hrTNF- and hrlL-8 on
neutrophil migration induced by FMLP. Cytokines were used at final
concentration of 10-7M and washed out prior to the use in
microchemotaxis assay. Results are reported as means +_ S.E.M. of the
number of neutrophils per field. (*p < 0.01, Student’s t-test.)
Discussion
Because it has been reported that both TNF and
IL-8 have inhibitory effects on neutrophil functions,
the effects of IL-8 and TNF- on neutrophil
chemotaxis induced by FMLP and peritoneal
emigration of neutrophils induced by carrageenan
were investigated. There have been controversial
findings on effect of TNF- on neutrophil
migration, depending on the assay method
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FIG. 4. Effect of intravenous pretreatment of rats with either mrTNF-,
hrlL-8 or both, upon carrageenan induced neutrophil migration into
peritoneal cavities. The dose of each cytokine was 2 lag/animal. Results
are means _+ S.E.M. of the number of animals given above each bar.
(*p < 0.01, Student’s t-test).
used. TNF inhibition of neutrophil migration
has consistently been seen with the agarose
method,2’26-28 while the chemotaxis chamber
methods have yielded contradictory conclu-
sions. 12’20’22’29 In the present experiments, hrTNF-0
and hrlL-8 inhibited neutrophil migration in vitro
in a dose dependent manner. While TNF-0 was
more potent than IL-8, the combination of these
cytokines had an additive inhibitory eect. The high
doses of hrlL-8 necessary to inhibit human PMN
chemotaxis suggests that the cytokine is acting by
crossreacting with a receptor for another ligand, or
through cross-desensitization.
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It is known that a high concentration of a
chemotactic factor placed in the upper compartment
of a chemotactic chember can inhibit neutrophil
chemotaxis.
3 However, the inhibitory effect de-
scribed in this paper was not due to the presence
of residual TNF- and IL-8 in the top chamber,
since exposure of the neutrophils to mrTNF-,
hrIL-8 or both, followed by cell washing, had the
same in vitro inhibitory effect.
Intravenous injection of a single dose (2/2g/ani-
mal) of hrlL-8 and/or mrTNF-cx before the
intraperitoneal administration of carrageenan
caused significant reduction of neutrophil accumu-
lation on rat peritoneal cavities. It has recently been
reported that systemic administration of TNF24’31
or It-82s’32’33 induces only a transient neutropenia
which is followed by neutrophilia. Thus, the
inhibitory effects observed in the present investi-
gation probably are not due to neutropenia.
It has been shown that IL-8 blocks neutrophil
adhesion to activated endothelial monolayers
23 as
well as inducing the loss of lectin adhesion molecule
I (LECAM-1) from the unstimulated neutrophil
surface, thereby reducing neutrophil adhesion to
vascular endothelium under conditions of flow.
34
These findings may explain the IL-8 induced
inhibitory effect observed here. The low efficiency
of IL-8 in comparison to TNF-a in rat studies
perhaps may be due to a weak recognition of hrIL-8
by rat PMN. In this regard, recent studies have
shown that IL-8 may have some species specificity
and then its chemotactic potency can vary according
to the PMN source.
Previous studies have suggested that TNF-cz
inhibits neutrophil migration in vitro by increasing
the expression of the CD11b, thus resulting in
enhancement of neutrophil adhesion and suppres-
sion of migration.
2 The authors showed that the
monoclonal antibody 60.1, which is directed against
an epitope on the alpha chain of the CD11b/CD18
complex,
36 completely blocked the inhibition of
neutrophil migration induced by hrTNF-. This
monoclonal antibody also completely reversed the
hrTNF- induced hyperadherence to gelatin-coated
wells.2 The TNF-cx induced inhibition of neu-
trophil emigration into peritoneal cavities described
in this paper, may also be due to the hyperadherence
of neutrophils in the circulation which impairs the
migration of these cells into extravascular space.
TNF- has been implicated as an important
mediator of Gram-negative sepsis, which involves
extensive polymorphonuclear mediated vascular
and tissue damage.
37 TNF- injection into experi-
mental animal produces a virtually identical ’septic
shock syndrome’ to endotoxin administration.
38
The animals passively immunized against TNF-
survive an otherwise lethal dose of endotoxin.
39 It
has recently been shown that IL-8 also appears in
the circulation of primates during septic shock,
sublethal endotoxaemia and after IL-1 administra-
tion.4 Thus, several events observed in the
endotoxaemia, such as impairment of neutrophil
migration, may be induced by release of IL-8 and
TNF-0. Recently Cunha and coworkers,
11 have
suggested that failure of neutrophils to migrat.e
during septicaemia or endotoxaemia may be the
result of a continuous release of a recruitment
inhibitory factor (NRIF). Since NRIF is present in
the supernatant of LPS pretreated macrophages,
and since LPS also stimulates macrophages release
IL-8 and TNF, probably part of inhibitory effect of
the macrophage crude supernatants is due to the
presence of TNF-cx and IL-8 in those samples.
In conclusion, the present findings suggest that
TNF- and IL-8 may be responsible for the
inhibition of neutrophil migration found in
septicaemia or endotoxaemia. Selective control of
TNF- and IL-8 or blockade of their effects on
neutrophil migration may be clinically useful in
reestablishing the cell defence mechanisms impaired
in inflammatory diseases.
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